F6Publishing

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Articles Published Processes

Keyword: Non-alcoholic Fatty Liver Disease

Page 1 of 8 ( 392 items )
<<
1
2
3
4
5
6
7
8
>>

1	Correlation between non-alcoholic fatty liver disease and erectile dysfunction: A systematic narrative review 4/21/2026 8:57:44 AM \| Browse: 30 \| Download: 129
2	Monocyte reprogramming and trained immunity: Linking metabolism to inflammation in non-alcoholic fatty liver disease 4/21/2026 8:57:42 AM \| Browse: 31 \| Download: 109
3	Interplay of childhood metabolic dysfunction-associated steatotic liver disease and obesity in the development of youth-onset type 2 diabetes 3/6/2026 8:56:27 AM \| Browse: 94 \| Download: 340
4	Dynamic immune response and influencing factors in COVID-19 patients with non-alcoholic fatty liver disease: A cohort study 2/12/2026 11:20:22 AM \| Browse: 82 \| Download: 417
5	Blood markers vs transient elastography for liver stiffness and steatosis in metabolic dysfunction-associated steatotic liver disease 1/27/2026 10:12:32 AM \| Browse: 125 \| Download: 317
6	Transcriptome profiles of peripheral blood mononuclear cells differentiate male adolescents with non-alcoholic fatty liver disease from healthy peers 12/26/2025 10:27:29 AM \| Browse: 83 \| Download: 382
7	Pathophysiology of depression and anxiety in metabolic dysfunction-associated steatotic liver disease 12/22/2025 7:43:01 AM \| Browse: 97 \| Download: 269
8	Clinical characteristics of colorectal polyps in patients with non-alcoholic fatty liver disease in high altitude areas 12/11/2025 8:21:00 AM \| Browse: 144 \| Download: 363
9	Influence of an internet-based proactive follow-up management model on the prognosis of nonalcoholic fatty liver disease 11/28/2025 3:10:39 AM \| Browse: 148 \| Download: 521
10	Redefining fatty liver as metabolic dysfunction-associated steatotic liver disease: Implications of nomenclature changes for patients with diabetes 11/27/2025 7:54:00 AM \| Browse: 104 \| Download: 318
11	Lysosomal acid lipase deficiency: The forgotten link between liver and cardiovascular disease 11/21/2025 5:52:41 AM \| Browse: 130 \| Download: 318
12	Mitochondrial transplantation and platelet rich plasma for the treatment of non-alcoholic fatty liver disease 10/27/2025 10:57:53 AM \| Browse: 283 \| Download: 457
13	Cholecystectomy and non-alcoholic fatty liver disease: Exploring the hidden connection and implications 10/24/2025 7:36:33 AM \| Browse: 257 \| Download: 344
14	Impact of non-alcoholic hepatic steatosis on prognosis and clinical outcomes in gastric cancer patients undergoing laparoscopic distal gastrectomy 9/24/2025 9:01:56 AM \| Browse: 229 \| Download: 515
15	Comparative evaluation of three traditional herbal formulas on gastrointestinal motility in a mouse model of cold stress-induced dyspepsia 9/18/2025 9:55:58 AM \| Browse: 559 \| Download: 589
16	Toxins to treatments: Impact of environmental pollutants, gut microbiota, and natural compounds on non-alcoholic fatty liver disease progression 8/27/2025 9:21:11 AM \| Browse: 319 \| Download: 498
17	Myths and facts about the role of diet in metabolic dysfunctionassociated steatotic liver disease 8/27/2025 9:21:10 AM \| Browse: 196 \| Download: 671
18	Duodenal mucosal ablation with irreversible electroporation in non-alcoholic fatty liver disease: Roadmap of the future treatment 8/27/2025 3:43:59 AM \| Browse: 243 \| Download: 479
19	TSC22D1 promotes liver sinusoidal endothelial cell dysfunction and induces macrophage M1 polarization in non-alcoholic fatty liver disease 8/18/2025 10:04:51 AM \| Browse: 109 \| Download: 495
20	Liver stiffness measurements in patients with metabolic dysfunction-associated steatotic liver disease: Updates on the method effectiveness and perspectives 7/25/2025 12:09:44 PM \| Browse: 193 \| Download: 480
21	MANPOWER study: Real-world post-hoc analysis assessing essential phospholipids for non-alcoholic fatty liver disease from the Russian registry 6/26/2025 7:27:55 AM \| Browse: 209 \| Download: 744
22	Gut microbiota in non-alcoholic fatty liver disease: Pathophysiology, diagnosis, and therapeutics 6/26/2025 7:27:54 AM \| Browse: 275 \| Download: 734
23	Metabolic-dysfunction associated steatotic liver disease and atrial fibrillation: A review of pathogenesis 6/20/2025 7:30:13 AM \| Browse: 134 \| Download: 562
24	Are mesenchymal stem/stromal cells a novel avenue for the treatment of non-alcoholic fatty liver disease? 5/26/2025 9:15:10 AM \| Browse: 216 \| Download: 634
25	Duodenal mucosal ablation with irreversible electroporation reduces liver lipids in rats with non-alcoholic fatty liver disease 4/27/2025 3:54:33 AM \| Browse: 178 \| Download: 779
26	Nonalcoholic fatty liver disease following laparoscopic duodenum-preserving pancreatic total head resection vs laparoscopic pancreaticoduodenectomy: A retrospective cohort study 4/2/2025 10:54:11 AM \| Browse: 216 \| Download: 923
27	Association of cardiovascular health metrics and metabolic associated fatty liver disease: Methodological limitations, and future directions 3/26/2025 4:06:53 AM \| Browse: 175 \| Download: 470
28	Induced pluripotent stem cells-derived mesenchymal stem cells for modelling and treating non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Challenges and opportunities 2/24/2025 5:39:17 AM \| Browse: 239 \| Download: 706
29	ILF3 inhibits p-AMPK expression to drive non-alcoholic fatty liver disease progression 2/20/2025 8:40:00 AM \| Browse: 205 \| Download: 936
30	Liver function linked to bone health: A bibliometric of the liver-bone axis 2/20/2025 8:39:56 AM \| Browse: 268 \| Download: 790
31	Role of triggering receptor expressed on myeloid cells 2 in the pathogenesis of non-alcoholic fatty liver disease 2/20/2025 8:39:45 AM \| Browse: 165 \| Download: 500
32	Roles of olive oil and physical exercise in non-alcoholic fatty liver disease after ultrasound-based evaluation 2/20/2025 8:39:33 AM \| Browse: 169 \| Download: 549
33	Association of non-alcoholic fatty liver disease with glycemic control among patients with type 2 diabetes mellitus at Limbe Regional Hospital, Southwest, Cameroon 2/20/2025 8:39:16 AM \| Browse: 233 \| Download: 898
34	Association between Helicobacter pylori infection and metabolic dysfunction-associated steatohepatitis: From an analysis of a population-based study 2/20/2025 8:38:48 AM \| Browse: 61 \| Download: 238
35	Oxidative stress-induced circSOD2 inhibits osteogenesis through sponging miR-29b in metabolic-associated fatty liver disease 2/18/2025 9:00:59 AM \| Browse: 239 \| Download: 1040
36	Herbal medicine as a potential treatment for non-alcoholic fatty liver disease 2/18/2025 9:00:45 AM \| Browse: 221 \| Download: 662
37	Role of 1,25-dihydroxyvitamin D3 in alleviating hepatic steatosis: Targeting M1 macrophage polarization in non-alcoholic fatty liver disease 2/14/2025 10:33:16 AM \| Browse: 207 \| Download: 681
38	Adenosine triphosphate-binding pocket inhibitor for mixed lineage kinase domain-like protein attenuated alcoholic liver disease via necroptosis-independent pathway 1/10/2025 8:40:02 AM \| Browse: 155 \| Download: 789
39	Critical assessment of the reported bidirectional associations between gallstone, non-alcoholic fatty liver, and kidney stone diseases 12/30/2024 9:49:58 AM \| Browse: 203 \| Download: 787
40	Exploring the therapeutic potential of glucagon-like peptide 1 agonists in metabolic disorders 12/30/2024 6:47:30 AM \| Browse: 167 \| Download: 569
41	Exploring the links between gallstone disease, non-alcoholic fatty liver disease, and kidney stones: A path to comprehensive prevention 12/30/2024 6:47:30 AM \| Browse: 219 \| Download: 521
42	Clinical profiles and their interaction of concurrent metabolic associated steatotic liver disease and hepatitis B virus infection 11/29/2024 2:50:17 PM \| Browse: 312 \| Download: 914
43	Exploring non-invasive diagnostics and non-imaging approaches for pediatric metabolic dysfunction-associated steatotic liver disease 11/26/2024 7:20:28 AM \| Browse: 259 \| Download: 724
44	Bidirectional associations among gallstone disease, non-alcoholic fatty liver disease, kidney stone disease 11/21/2024 7:04:51 AM \| Browse: 213 \| Download: 811
45	Insights from exploring the interrelated dynamics of gallstone disease, non-alcoholic fatty liver disease, and kidney stone disease 11/21/2024 7:04:50 AM \| Browse: 194 \| Download: 627
46	Vitamin D 1,25-Dihydroxyvitamin D₃ reduces lipid accumulation in hepatocytes by inhibiting M1 macrophage polarization 11/12/2024 12:23:35 PM \| Browse: 263 \| Download: 965
47	Machine learning applications in healthcare clinical practice and research 11/7/2024 5:10:59 AM \| Browse: 197 \| Download: 686
48	Bioactive constituents and action mechanism of Xiaoyao San for treatment of non-alcoholic fatty liver disease 10/21/2024 7:03:25 AM \| Browse: 242 \| Download: 827
49	Systemic treatment of hepatocellular carcinoma secondary to non-alcoholic fatty liver disease 10/14/2024 7:12:19 AM \| Browse: 208 \| Download: 558
50	Innovative mesenchymal stem cell treatments for fatty liver disease 9/24/2024 3:15:41 AM \| Browse: 183 \| Download: 687

Page 1 of 8 ( 392 items )
<<
1
2
3
4
5
6
7
8
>>

1	Correlation between non-alcoholic fatty liver disease and erectile dysfunction: A systematic narrative review 4/21/2026 8:57:44 AM \| Browse: 30 \| Download: 129
2	Monocyte reprogramming and trained immunity: Linking metabolism to inflammation in non-alcoholic fatty liver disease 4/21/2026 8:57:42 AM \| Browse: 31 \| Download: 109
3	Interplay of childhood metabolic dysfunction-associated steatotic liver disease and obesity in the development of youth-onset type 2 diabetes 3/6/2026 8:56:27 AM \| Browse: 94 \| Download: 340
4	Dynamic immune response and influencing factors in COVID-19 patients with non-alcoholic fatty liver disease: A cohort study 2/12/2026 11:20:22 AM \| Browse: 82 \| Download: 417
5	Blood markers vs transient elastography for liver stiffness and steatosis in metabolic dysfunction-associated steatotic liver disease 1/27/2026 10:12:32 AM \| Browse: 125 \| Download: 317
6	Transcriptome profiles of peripheral blood mononuclear cells differentiate male adolescents with non-alcoholic fatty liver disease from healthy peers 12/26/2025 10:27:29 AM \| Browse: 83 \| Download: 382
7	Pathophysiology of depression and anxiety in metabolic dysfunction-associated steatotic liver disease 12/22/2025 7:43:01 AM \| Browse: 97 \| Download: 269
8	Clinical characteristics of colorectal polyps in patients with non-alcoholic fatty liver disease in high altitude areas 12/11/2025 8:21:00 AM \| Browse: 144 \| Download: 363
9	Influence of an internet-based proactive follow-up management model on the prognosis of nonalcoholic fatty liver disease 11/28/2025 3:10:39 AM \| Browse: 148 \| Download: 521
10	Redefining fatty liver as metabolic dysfunction-associated steatotic liver disease: Implications of nomenclature changes for patients with diabetes 11/27/2025 7:54:00 AM \| Browse: 104 \| Download: 318
11	Lysosomal acid lipase deficiency: The forgotten link between liver and cardiovascular disease 11/21/2025 5:52:41 AM \| Browse: 130 \| Download: 318
12	Mitochondrial transplantation and platelet rich plasma for the treatment of non-alcoholic fatty liver disease 10/27/2025 10:57:53 AM \| Browse: 283 \| Download: 457
13	Cholecystectomy and non-alcoholic fatty liver disease: Exploring the hidden connection and implications 10/24/2025 7:36:33 AM \| Browse: 257 \| Download: 344
14	Impact of non-alcoholic hepatic steatosis on prognosis and clinical outcomes in gastric cancer patients undergoing laparoscopic distal gastrectomy 9/24/2025 9:01:56 AM \| Browse: 229 \| Download: 515
15	Comparative evaluation of three traditional herbal formulas on gastrointestinal motility in a mouse model of cold stress-induced dyspepsia 9/18/2025 9:55:58 AM \| Browse: 559 \| Download: 589
16	Toxins to treatments: Impact of environmental pollutants, gut microbiota, and natural compounds on non-alcoholic fatty liver disease progression 8/27/2025 9:21:11 AM \| Browse: 319 \| Download: 498
17	Myths and facts about the role of diet in metabolic dysfunctionassociated steatotic liver disease 8/27/2025 9:21:10 AM \| Browse: 196 \| Download: 671
18	Duodenal mucosal ablation with irreversible electroporation in non-alcoholic fatty liver disease: Roadmap of the future treatment 8/27/2025 3:43:59 AM \| Browse: 243 \| Download: 479
19	TSC22D1 promotes liver sinusoidal endothelial cell dysfunction and induces macrophage M1 polarization in non-alcoholic fatty liver disease 8/18/2025 10:04:51 AM \| Browse: 109 \| Download: 495
20	Liver stiffness measurements in patients with metabolic dysfunction-associated steatotic liver disease: Updates on the method effectiveness and perspectives 7/25/2025 12:09:44 PM \| Browse: 193 \| Download: 480
21	MANPOWER study: Real-world post-hoc analysis assessing essential phospholipids for non-alcoholic fatty liver disease from the Russian registry 6/26/2025 7:27:55 AM \| Browse: 209 \| Download: 744
22	Gut microbiota in non-alcoholic fatty liver disease: Pathophysiology, diagnosis, and therapeutics 6/26/2025 7:27:54 AM \| Browse: 275 \| Download: 734
23	Metabolic-dysfunction associated steatotic liver disease and atrial fibrillation: A review of pathogenesis 6/20/2025 7:30:13 AM \| Browse: 134 \| Download: 562
24	Are mesenchymal stem/stromal cells a novel avenue for the treatment of non-alcoholic fatty liver disease? 5/26/2025 9:15:10 AM \| Browse: 216 \| Download: 634
25	Duodenal mucosal ablation with irreversible electroporation reduces liver lipids in rats with non-alcoholic fatty liver disease 4/27/2025 3:54:33 AM \| Browse: 178 \| Download: 779
26	Nonalcoholic fatty liver disease following laparoscopic duodenum-preserving pancreatic total head resection vs laparoscopic pancreaticoduodenectomy: A retrospective cohort study 4/2/2025 10:54:11 AM \| Browse: 216 \| Download: 923
27	Association of cardiovascular health metrics and metabolic associated fatty liver disease: Methodological limitations, and future directions 3/26/2025 4:06:53 AM \| Browse: 175 \| Download: 470
28	Induced pluripotent stem cells-derived mesenchymal stem cells for modelling and treating non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Challenges and opportunities 2/24/2025 5:39:17 AM \| Browse: 239 \| Download: 706
29	ILF3 inhibits p-AMPK expression to drive non-alcoholic fatty liver disease progression 2/20/2025 8:40:00 AM \| Browse: 205 \| Download: 936
30	Liver function linked to bone health: A bibliometric of the liver-bone axis 2/20/2025 8:39:56 AM \| Browse: 268 \| Download: 790
31	Role of triggering receptor expressed on myeloid cells 2 in the pathogenesis of non-alcoholic fatty liver disease 2/20/2025 8:39:45 AM \| Browse: 165 \| Download: 500
32	Roles of olive oil and physical exercise in non-alcoholic fatty liver disease after ultrasound-based evaluation 2/20/2025 8:39:33 AM \| Browse: 169 \| Download: 549
33	Association of non-alcoholic fatty liver disease with glycemic control among patients with type 2 diabetes mellitus at Limbe Regional Hospital, Southwest, Cameroon 2/20/2025 8:39:16 AM \| Browse: 233 \| Download: 898
34	Association between Helicobacter pylori infection and metabolic dysfunction-associated steatohepatitis: From an analysis of a population-based study 2/20/2025 8:38:48 AM \| Browse: 61 \| Download: 238
35	Oxidative stress-induced circSOD2 inhibits osteogenesis through sponging miR-29b in metabolic-associated fatty liver disease 2/18/2025 9:00:59 AM \| Browse: 239 \| Download: 1040
36	Herbal medicine as a potential treatment for non-alcoholic fatty liver disease 2/18/2025 9:00:45 AM \| Browse: 221 \| Download: 662
37	Role of 1,25-dihydroxyvitamin D3 in alleviating hepatic steatosis: Targeting M1 macrophage polarization in non-alcoholic fatty liver disease 2/14/2025 10:33:16 AM \| Browse: 207 \| Download: 681
38	Adenosine triphosphate-binding pocket inhibitor for mixed lineage kinase domain-like protein attenuated alcoholic liver disease via necroptosis-independent pathway 1/10/2025 8:40:02 AM \| Browse: 155 \| Download: 789
39	Critical assessment of the reported bidirectional associations between gallstone, non-alcoholic fatty liver, and kidney stone diseases 12/30/2024 9:49:58 AM \| Browse: 203 \| Download: 787
40	Exploring the therapeutic potential of glucagon-like peptide 1 agonists in metabolic disorders 12/30/2024 6:47:30 AM \| Browse: 167 \| Download: 569
41	Exploring the links between gallstone disease, non-alcoholic fatty liver disease, and kidney stones: A path to comprehensive prevention 12/30/2024 6:47:30 AM \| Browse: 219 \| Download: 521
42	Clinical profiles and their interaction of concurrent metabolic associated steatotic liver disease and hepatitis B virus infection 11/29/2024 2:50:17 PM \| Browse: 312 \| Download: 914
43	Exploring non-invasive diagnostics and non-imaging approaches for pediatric metabolic dysfunction-associated steatotic liver disease 11/26/2024 7:20:28 AM \| Browse: 259 \| Download: 724
44	Bidirectional associations among gallstone disease, non-alcoholic fatty liver disease, kidney stone disease 11/21/2024 7:04:51 AM \| Browse: 213 \| Download: 811
45	Insights from exploring the interrelated dynamics of gallstone disease, non-alcoholic fatty liver disease, and kidney stone disease 11/21/2024 7:04:50 AM \| Browse: 194 \| Download: 627
46	Vitamin D 1,25-Dihydroxyvitamin D₃ reduces lipid accumulation in hepatocytes by inhibiting M1 macrophage polarization 11/12/2024 12:23:35 PM \| Browse: 263 \| Download: 965
47	Machine learning applications in healthcare clinical practice and research 11/7/2024 5:10:59 AM \| Browse: 197 \| Download: 686
48	Bioactive constituents and action mechanism of Xiaoyao San for treatment of non-alcoholic fatty liver disease 10/21/2024 7:03:25 AM \| Browse: 242 \| Download: 827
49	Systemic treatment of hepatocellular carcinoma secondary to non-alcoholic fatty liver disease 10/14/2024 7:12:19 AM \| Browse: 208 \| Download: 558
50	Innovative mesenchymal stem cell treatments for fatty liver disease 9/24/2024 3:15:41 AM \| Browse: 183 \| Download: 687